title: Treatment of acute C hepatitis in HIV-infected patients.
authors.forename: Sabrina
authors.initials: S
authors.lastname: Audagnotto
authors.forename: Francesco Giuseppe
authors.initials: FG
authors.lastname: De Rosa
authors.forename: Olivia
authors.initials: O
authors.lastname: Bargiacchi
authors.forename: Silvia
authors.initials: S
authors.lastname: Garazzino
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Veronese
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Cariti
authors.forename: Giovanni
authors.initials: G
authors.lastname: Di Perri
mesh_terms: D000208:Acute Disease; D000328:Adult; D021121:Branched DNA Signal Amplification Assay; D005260:Female; D015658:HIV Infections / Q000150:complications*; D016174:Hepacivirus / Q000235:genetics / Q000302:isolation & purification; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D020133:Reverse Transcriptase Polymerase Chain Reaction; D016896:Treatment Outcome; D019562:Viral Load
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b